ONYX PHARMACEUTICALS INC Net Cash Provided by (Used in) Continuing Operations
ONYX PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Continuing Operations of $169.82 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2013-06-30 was -$113.45M, a 255.03% decline year-over-year.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2013-03-31 was $283.28M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-12-31 was -$76.01M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) continuing operations for the quarter ending 2012-09-30 was $23.05M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2012 was -$18.31M.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2011 was -$54.79M, a 146.17% decline from fiscal 2010.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) continuing operations for fiscal 2010 was $118.67M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$113.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $169.82M 10-Q · filed 2013-08-09 | $93.82M derived: sum of 3 quarters · filed 2013-08-09 | $116.86M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $283.28M 10-Q · filed 2013-05-08 | $207.27M derived: sum of 2 quarters · filed 2013-05-08 | $230.31M derived: sum of 3 quarters · filed 2013-05-08 | $303.50M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | -$76.01M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$52.96M derived: sum of 2 quarters · filed 2013-02-28 | $20.22M derived: sum of 3 quarters · filed 2013-08-09 | -$18.31M 10-K · filed 2013-02-28 |
| 2012-09-30 | $23.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $96.23M derived: sum of 2 quarters · filed 2013-08-09 | $57.70M 10-Q · filed 2012-11-02 | $9.88M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $73.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $34.65M 10-Q · filed 2013-08-09 | -$13.16M derived: sum of 3 quarters · filed 2013-08-09 | |
| 2012-03-31 | -$38.53M 10-Q · filed 2013-05-08 | -$86.34M derived: sum of 2 quarters · filed 2013-05-08 | ||
| 2011-12-31 | -$47.81M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$54.79M 10-K · filed 2013-02-28 | ||
| 2011-09-30 | -$6.97M 10-Q · filed 2012-11-02 | |||
| 2010-12-31 | $118.67M 10-K · filed 2013-02-28 |